Sage Rhino Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $620K | Sell |
|
|||||
|
2025
Q2 | $803K | Sell |
|
|||||
|
2025
Q1 | $821K | Sell |
|
|||||
|
2024
Q4 | $1.04M | Sell |
|
|||||
|
2024
Q3 | $1.47M | Buy |
|
|||||
|
2024
Q2 | $1.76M | Buy |
|
|||||
|
2024
Q1 | $1.58M | Buy |
|
|||||
|
2023
Q4 | $1.27M | Buy |
|
|||||
|
2023
Q3 | $1.11M | Buy |
|
|||||
|
2023
Q2 | $971K | Sell |
|
|||||
|
2023
Q1 | $978K | Buy |
|
|||||
|
2022
Q4 | $818K | Buy |
|
|||||
|
2022
Q3 | $583K | Sell |
|
|||||
|
2022
Q2 | $668K | Buy |
|
|||||
|
2022
Q1 | $653K | Buy |
|
|||||
|
2021
Q4 | $630K | Buy |
|
|||||
|
2021
Q3 | $485K | Buy |
|
|||||
|
2021
Q2 | $410K | Buy |
|
|||||
|
2021
Q1 | $314K | Buy |
|
|||||
|
2020
Q4 | $310K | Buy |
|
|||||
|
2020
Q3 | $308K | Sell |
|
|||||
|
2020
Q2 | $291K | Buy |
|
|||||
|
2020
Q1 | $260K | Buy |
|
|||||
|
2019
Q4 | $231K | Buy |
|
|||||
|
2019
Q3 | $201K | Sell |
|
|||||
|
2019
Q2 | $202K | Buy |
|